Related Experiment Video
Updated: May 18, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Inverse relationship between TCTP/RhoA and p53 /cyclin A/actin expression in ovarian cancer cells
Malgorzata Kloc1, Neelam Tejpal, Jitinderpal Sidhu
1Department of Surgery, The Methodist Hospital, Houston, TX 77030, USA.
Abstract:
The translationally controlled tumor protein (TCTP) plays a role in cell growth, cell cycle and cancer progression. TCTP controls negatively the stability of the p53 tumor suppressor protein and interacts with the cellular cytoskeleton. The deregulation of the actin and cytokeratin cytoskeleton is responsible for the increased migratory activity of tumor cells and is linked with poor patient outcome. Recent studies indicate that cyclin A,a key regulator of cell cycle, controls actin organization and negatively regulates cell motility via regulation of RhoA expression. We studied the organization of actin and cytokeratin cytoskeleton and the expression of TCTP, p53,cyclin A, RhoA and actin in HIO180 non-transformed ovarian epithelial cells, and OVCAR3 and SKOV3 (expressing low level of inducible p53) ovarian epithelial cancer cells with different metastatic potential. Immunostaining and ultrastructural analyses illustrated a dramatic difference in the organization of the cytokeratin and actin filaments in non-transformed versus cancer cell lines. We also determined that there is an inverse relationship between the level of TCTP/RhoA and actin/p53/cyclin A expression in ovarian cancer cell lines. This previously unidentified negative relationship between TCTP/RhoA and actin/p53/cyclin A may suggest that this interaction is linked with the high aggressiveness of ovarian cancers.
Insights
Translationally controlled tumor protein (TCTP) and RhoA inversely correlate with actin, p53, and cyclin A in ovarian cancer cells. This interaction may drive aggressive ovarian cancer progression.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- The translationally controlled tumor protein (TCTP) influences cell growth, cell cycle, and cancer progression.
- TCTP negatively affects p53 stability and interacts with the cytoskeleton, while cytoskeleton deregulation correlates with tumor cell migration and poor patient outcomes.
- Cyclin A regulates the cell cycle, controls actin organization, and impacts cell motility via RhoA.
Purpose of the Study:
- To investigate the organization of actin and cytokeratin cytoskeleton.
- To examine the expression of TCTP, p53, cyclin A, RhoA, and actin.
- To compare these factors in non-transformed ovarian epithelial cells and ovarian cancer cell lines with varying metastatic potential.
Main Methods:
- Immunostaining
- Ultrastructural analyses
- Expression analysis of key proteins (TCTP, p53, cyclin A, RhoA, actin)
Main Results:
- Significant differences in actin and cytokeratin organization were observed between non-transformed and cancer cells.
- An inverse relationship was identified between TCTP/RhoA levels and actin/p53/cyclin A expression in ovarian cancer cell lines.
- These findings highlight distinct cytoskeletal and molecular profiles in ovarian cancer.
Conclusions:
- The study reveals a novel inverse relationship between TCTP/RhoA and actin/p53/cyclin A in ovarian cancer.
- This interaction may be a critical factor contributing to the high aggressiveness of ovarian cancers.
- Understanding these molecular dynamics could offer new therapeutic targets for ovarian cancer.
More Related Videos
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
12:42Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Published on: August 28, 2012
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Inhibition of Cdk Activity
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...